Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

40 та иш

Иш: Circulating tumor DNA as a predictive biomarker for colorectal cancer postsurgical recurrence: a systematic review and meta-analysis

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

    Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel +4

    МақолаGlobal Cancer Incidence and ScreeningCA A Cancer Journal for Clinicians202160 иқтибос
    ABI

  2. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

    Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt +23

    Мақола202155 иқтибос
    ABI

  3. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

    Freddie Bray, Mathieu Laversanne, Hyuna Sung +4

    Мақола202419 иқтибос
    ABI

  4. Bias in meta-analysis detected by a simple, graphical test

    Matthias Egger, George Davey Smith, Martin Schneider +1

    Мақола199712 иқтибос
    ABI

  5. Measuring inconsistency in meta-analyses

    Julian P. T. Higgins, Simon G. Thompson, Jonathan J Deeks +1

    Шарҳ мақола200311 иқтибос
    ABI

  6. Meta-analysis in clinical trials

    Rebecca DerSimonian, Nan M. Laird

    Мақола19868 иқтибос
    ABI

  7. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

    Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen +35

    Мақола20194 иқтибос
    ABI

  8. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

    Jeanne Tie, Joshua D. Cohen, Yuxuan Wang +21

    Мақола20193 иқтибос
    ABI

  9. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

    Jeanne Tie, Yuxuan Wang, Cristian Tomasetti +23

    Мақола20163 иқтибос
    ABI

  10. Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA

    Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland +3

    Шарҳ мақола20233 иқтибос
    ABI

  11. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

    Andreas Stang

    Мақола20102 иқтибос
    ABI

  12. Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging

    J. B. O'Connell, Melinda A. Maggard, Clifford Y. Ko

    Мақола20042 иқтибос
    ABI

  13. Liquid biopsy and minimal residual disease — latest advances and implications for cure

    Klaus Pantel, Catherine Alix‐Panabières

    Шарҳ мақола20192 иқтибос
    ABI

  14. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)

    R Chin, Kevin Chen, Abul Usmani +6

    Шарҳ мақола20192 иқтибос
    ABI

  15. Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease

    Everett J. Moding, Barzin Y. Nabet, Ash A. Alizadeh +1

    Шарҳ мақола20212 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI